Skip to content
MarketNewsAPI
Product Live news Screener Coverage Pricing
Docs Overview REST API WebSocket API MCP server
Resources Use cases Blog Changelog Status Compare Contact
Log in Get API key Dashboard
GS$867.10-61.18(-6.59%)UPDATE 1-Goldman Sachs lowers gold price forecasts on hawkish Fed outlook5:22:31 PM ETMRNA$233.90-24.44(-9.46%)Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines5:20:44 PM ETAMPH$29.45+1.43(+5.10%)Amphastar Q3 revenue rises, beats expectations5:16:44 PM ETTMO$676.940.00(0.00%)Thermo Fisher Scientific Authorizes $5 Billion of Share Repurchases5:15:01 PM ETPNC$226.750.00(0.00%)PNC names Alexander Overstrom as CFO, succeeding Robert Reilly5:14:20 PM ETDOCU$78.69-1.81(-2.25%)Docusign vs. Monday.com: Which Technology Stock Is a Better Buy for 2027?5:13:02 PM ETRKLB$45.70-6.53(-12.50%)Why Rocket Lab Stock Dropped Today5:11:01 PM ETCOST$1,062.00-3.59(-0.34%)Jim Cramer Says Costco Is Still a Great Value. Charlie Munger's Rule Explains Why5:07:28 PM ETSVM$8.18-0.16(-1.92%)SILVERCORP REPORTS ADJUSTED NET INCOME OF $18.4 MILLION, $0.08 PER SHARE, AND CASH FLOW FROM OPERATING ACTIVITIES OF $62.7 MILLION FOR Q2 FISCAL 20275:06:04 PM ETABNB$187.36+10.99(+6.23%)Airbnb Shares Climb on Q3 Earnings Double-Beat: Details5:05:49 PM ETNET$284.23+39.72(+16.24%)Cloudflare Q3 revenue beats estimates on AI platform demand5:05:25 PM ETINTC$51.68-6.60(-11.32%)Stock Market Today, Nov. 5: Intel Falls on Weak Fourth-Quarter Sales Outlook Amid Chip Selloff5:02:16 PM ETTMO$676.940.00(0.00%)Thermo Fisher Scientific Announces Quarterly Dividend5:00:04 PM ETWPM$129.11-3.35(-2.53%)Wheaton Precious Metals Announces Third Quarter 2026 Results and Record Year-to-Date Production, Sales Volume, Revenue, Earnings and Cash Flow5:00:00 PM ETTSX:SAP$41.620.00(0.00%)Saputo Reports Financial Results for the Second Quarter of Fiscal 2027 Ended September 30, 20265:00:00 PM ETNET$284.23+39.72(+16.24%)Cloudflare Stock Surges on Lifted Full-Year Outlook, Third-Quarter Revenue Growth5:00:00 PM ETMNST$44.66-3.17(-6.63%)Monster Beverage Q3 sales beat estimates as marketing investments boost results4:56:44 PM ETEOG$144.890.00(0.00%)UPDATE 2-US shale producer EOG Resources beats profit estimates on higher crude prices4:55:18 PM ETCVX$213.50+0.57(+0.27%)Chevron (CVX) Price Forecast: Critical Support Faces First Major Test4:54:45 PM ETAAPL$342.64-6.92(-1.98%)Market Close: Stocks Tumble, Apple To Sell $7B In Debt, Wendy's Rejects Buyout Bid 11-5-20264:52:29 PM ETANTUPDATE 1-A&O Shearman's $1.1 billion AI plan builds on law firms' tech investments4:51:58 PM ETDNA$9.51-0.45(-4.52%)Ginkgo Bioworks Q3 revenue falls compared to last year4:51:51 PM ETABX$8.83-0.22(-2.43%)Abacus Global Management Q3 revenue, adjusted EBITDA beat estimates4:51:39 PM ETPRTA$7.89-0.50(-5.96%)Prothena Q3 net loss narrows on lower costs4:51:15 PM ET

TXG · NASDAQ

10x Genomics, Inc.

$50.96 -16.52 (-24.48%)

Company overview

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromatin (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cell…

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Exchange
NASDAQ
Market cap
$6.1B
Employees
1,306
Headquarters
Pleasanton, CA
Website
10xgenomics.com
CEO
Serge Saxonov
Listed
September 12, 2019
P/E
-299.76
Dividend yield
0.00%

Company financials

Revenue
$639M
Gross profit
$445M
Operating income
-$38.7M
EBITDA
-$5.9M
Net income
-$22.7M
EPS
-$0.17
Total assets
$1B
Total debt
$81.4M
Gross margin
69.60%
Net margin
-3.55%
Earnings yield
-0.33%

Revenue segmentation

By product (FY 2025)
By region (FY 2025)

Showing FY 2025

Price chart

16.5038.9161.3283.72106.13
TXG 1D NASDAQ O68.25H68.32L62.88C67.52+2.23 (+3.42%)Vol2.92M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Start 7-day free trial See live plans
Source
Date
Type
View
Ticker Type Headline Source Published
TXG10x Genomics, Inc. Stock news 10x Genomics Q3 revenue beats expectations; 2026 outlook lifted Reuters
TXG10x Genomics, Inc. Stock news BRIEF-10X Genomics Q3 Revenue USD 150.7 Million Vs. IBES Estimate USD 147.9 Million Reuters
TXG10x Genomics, Inc. Press release 10x Genomics Reports Third Quarter 2026 Financial Results PR Newswire
TXG10x Genomics, Inc. Stock news Torex Gold Resources (TSE:TXG) Share Price Crosses Above 200-Day Moving Average – Here’s Why Defense World
TXG10x Genomics, Inc. Press release 10x Genomics Launches Sentira Single Cell, A New Agentic AI Experience for Chromium Analysis PR Newswire
TXG10x Genomics, Inc. Press release 10x Genomics Launches Sentira Single Cell, A New Agentic AI Experience for Chromium Analysis 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, today announced t… PR Newswire
TXG10x Genomics, Inc. Press release Torex Gold Changes Name to Torex Resources Newsfile
TXG10x Genomics, Inc. Press release 10x Genomics to Participate in the 2026 Jefferies Global Healthcare Conference 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, announced today that ... PR Newswire
NZAUF Press release A 16% Month for Gold Miners Puts Grade, Costs and By-Products Back in Charge GlobeNewswire
TXG10x Genomics, Inc. Press release Torex Gold Welcomes Lee Hodgkinson to Its Board of Directors Newsfile
TXG10x Genomics, Inc. Stock news A Look at 10x Genomics Inc (TXG) After 3.5% Decline -- GF Value $18.31 vs Price $69.86 GuruFocus
TXG10x Genomics, Inc. Press release 10x Genomics to Report Third Quarter 2026 Financial Results on November 5, 2026 10x Genomics, Inc. (Nasdaq: TXG), the life science technology leader focused on accelerating science and advancing human health, announced it will... PR Newswire
TXG10x Genomics, Inc. Stock news These 3 Stocks Are Crushing the "Magnificent Seven" This Year -- Are They Still Buys? Fool - Investing News
TXG10x Genomics, Inc. Stock news 10x Genomics & Fred Hutch Join Forces on Cancer Biomarker Research Zacks Investment Research
TXG10x Genomics, Inc. Press release 10x Genomics Announces New Collaboration to Advance Single Cell and Spatial Applications Across Solid Tumors and Blood Cancers PRNewsWire
TXG10x Genomics, Inc. Stock news Torex Gold Targets Growth, C$350M Returns and Morelos Expansion Defense World
TXG10x Genomics, Inc. Stock news 10x Genomics Begins Atera Shipments as Spatial Biology Demand Rises Zacks Investment Research
TXG10x Genomics, Inc. Press release 10x Genomics Announces Sentira, a New Computational Platform to Turn Complex Biological Data Into Experimental Conclusions PR Newswire
TXG10x Genomics, Inc. Press release 10x Genomics Begins Global Shipments of Atera, Putting Unprecedented Spatial Biology Capabilities in Researchers' Hands PR Newswire
TXG10x Genomics, Inc. Stock news This Lexicon Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday Benzinga
See more
FAQ

Questions about 10x Genomics, Inc.

What does 10x Genomics, Inc. do?
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromatin (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cell…
What is TXG's market cap?
10x Genomics, Inc. (TXG) is a listed stock with a live quote. The latest market cap on this page is $6.1B.
Where is 10x Genomics, Inc. headquartered?
10x Genomics, Inc. is headquartered in Pleasanton, CA.
How do I get TXG news from the API?
Call GET /v1/news?tickers=TXG. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search articles since 2020 in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees articles since 2020.
How far back does TXG news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for TXG, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees articles since 2020 as headlines are ingested. A Free API key returns the last year. Pro keys search articles since 2020.
Is the TXG price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.
Can I use the Pro plan commercially?
No. The Pro plan cannot be used for commercial work. A product you sell, work you do for a client, or redistribution of the feed needs a custom plan and a license. Email [email protected].

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 250 REST requests a day, 1 WebSocket connection, 5 requests per second, and 2,500 WebSocket messages a day. You won't be charged during the trial. Unless you cancel, the card is billed for Pro when it ends.

Start 7-day free trial Read the docs